You have 3 free guides left 😟
Unlock your guides
You have 3 free guides left 😟
Unlock your guides

7.2 Stem Cell Differentiation and Reprogramming

4 min readjuly 24, 2024

Stem cell differentiation transforms cells into specialized types through complex processes. Factors like extracellular signals, cell interactions, and mechanical forces guide this journey. Signaling pathways and epigenetic changes orchestrate the cellular responses that shape differentiation.

Directed differentiation strategies aim to mimic the natural environment and control cell fate. While challenges like heterogeneity and scalability exist, these approaches offer exciting potential for . Quality control and safety considerations are crucial for therapeutic applications.

Stem Cell Differentiation

Process of stem cell differentiation

Top images from around the web for Process of stem cell differentiation
Top images from around the web for Process of stem cell differentiation
  • Stem cell differentiation process transforms pluripotent cells into specialized cell types
    • Loss of pluripotency markers (Oct4, Nanog) gradually decreases stem cell potential
    • Acquisition of specialized cell characteristics shapes distinct morphology and function
    • Changes in gene expression patterns activate lineage-specific genes (MyoD for muscle, GATA4 for cardiac)
  • Factors influencing cell fate decisions guide differentiation trajectory
    • Extracellular signals provide chemical cues (, cytokines, hormones)
    • Cell-cell interactions facilitate communication through direct contact or paracrine signaling
    • Mechanical forces exert physical stimuli (substrate stiffness, shear stress)
    • Oxygen tension modulates cellular metabolism and gene expression (hypoxia in stem cell niches)
  • Signaling pathways involved in differentiation orchestrate cellular responses
    • Wnt pathway regulates cell fate and patterning (β-catenin translocation)
    • Notch pathway mediates cell-cell communication and lateral inhibition
    • influences mesenchymal and osteogenic differentiation
  • Epigenetic changes during differentiation remodel chromatin landscape
    • DNA methylation silences pluripotency genes and activates lineage-specific genes
    • Histone modifications (acetylation, methylation) alter chromatin accessibility
  • Temporal and spatial regulation of differentiation ensures proper tissue development
  • Asymmetric cell division in stem cells maintains stem cell pool while producing differentiated progeny

Strategies for directed differentiation

  • Manipulation of culture conditions mimics in vivo microenvironment
    • Growth factor cocktails stimulate specific lineages (bFGF for neural, BMP4 for mesoderm)
    • Small molecule inhibitors/activators target key signaling pathways (CHIR99021 for Wnt activation)
    • Genetic modification introduces lineage-specific transcription factors (Ngn2 for neurons)
  • Challenges in directed differentiation hinder clinical translation
    • Heterogeneity of differentiated populations reduces therapeutic efficacy
    • Scalability of protocols limits large-scale production for clinical use
    • Maturation of differentiated cells often requires extended culture periods
    • Functional integration in vivo faces hurdles of cell survival and proper connectivity
  • Applications in regenerative medicine offer potential treatments
    • Neuronal differentiation for Parkinson's disease replaces lost dopaminergic neurons
    • Cardiomyocyte differentiation for heart repair aims to restore cardiac function
    • Pancreatic β-cell differentiation for diabetes targets insulin production
  • Quality control and safety considerations ensure therapeutic safety
    • Tumor formation risk necessitates rigorous screening for undifferentiated cells
    • Immunogenicity of differentiated cells may require immunosuppression or genetic modification
  • In vivo vs in vitro differentiation approaches offer complementary strategies
  • Biomaterial scaffolds for 3D differentiation provide structural and biochemical cues

Cellular Reprogramming

Concept of cellular reprogramming

  • Cellular reprogramming converts somatic cells to pluripotent state through epigenetic remodeling
  • (iPSCs) revolutionized stem cell research
    • Discovery by Shinya Yamanaka in 2006 earned Nobel Prize
    • Comparison to reveals similar potency and differentiation capacity
  • Methods of reprogramming offer various approaches
    • Transcription factor-based reprogramming uses Yamanaka factors (Oct4, Sox2, Klf4, c-Myc)
    • Small molecule-based reprogramming employs chemical compounds (valproic acid, CHIR99021)
    • microRNA-based reprogramming utilizes specific miRNAs (miR-302/367 cluster)
  • Applications of cellular reprogramming span research and clinical domains
    • Disease modeling creates patient-specific cell lines for studying pathogenesis
    • Drug screening utilizes iPSC-derived cells for toxicity and efficacy testing
    • Personalized medicine tailors treatments based on patient-specific responses
    • Regenerative therapies aim to replace damaged tissues with autologous cells
  • Advantages of patient-specific stem cells offer personalized approach
    • Reduced immune rejection due to genetic match with patient
    • Ethical considerations avoid embryo destruction controversy
  • Limitations and challenges persist in reprogramming field
    • Low efficiency of reprogramming (0.1-1% success rate) hinders large-scale production
    • Genomic instability introduces mutations during reprogramming process
    • Epigenetic memory retains aspects of original cell type, affecting differentiation potential

Regulation of stem cell fate

  • Key transcription factors in stem cell biology orchestrate gene expression networks
    • Oct4, Sox2, Nanog maintain pluripotency in embryonic stem cells
    • MyoD drives myogenic differentiation in skeletal muscle progenitors
    • NeuroD promotes neuronal differentiation in neural precursors
  • Transcription factor networks form complex regulatory systems
    • Autoregulatory loops reinforce cell state (Oct4-Sox2-Nanog in pluripotency)
    • Feedback mechanisms fine-tune gene expression levels
  • Epigenetic modifications in stem cells shape chromatin landscape
    • DNA methylation patterns silence or activate specific genes
    • Histone modifications (acetylation, methylation) alter chromatin accessibility
    • Chromatin remodeling complexes (SWI/SNF, CHD) restructure nucleosome positioning
  • Epigenetic landscape changes during differentiation guide
    • Bivalent chromatin domains mark developmental genes poised for activation
    • Polycomb and Trithorax complexes regulate gene repression and activation
  • Epigenetic barriers to reprogramming challenge cellular plasticity
    • DNA demethylation removes epigenetic marks of somatic cells
    • Histone deacetylase inhibitors (valproic acid) enhance reprogramming efficiency
  • Pioneer transcription factors initiate cellular reprogramming
    • Definition: TFs capable of binding closed chromatin and initiating remodeling
    • Role in reprogramming: Oct4 and Sox2 act as pioneer factors in iPSC generation
  • Epigenetic memory in reprogrammed cells influences differentiation potential
  • Long non-coding RNAs in stem cell regulation fine-tune gene expression networks
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Glossary
Glossary